文献速递造血干细胞移植与细胞治疗

单倍体造血干细胞移植后环磷酰胺对T细胞和NK细胞重建的影响

Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide.
PubMed 文献 · Blood Adv · 2021-01-01

该研究监测了60例接受单倍体造血干细胞移植(haplo-HCT)后环磷酰胺(PTCy)治疗及35例接受HLA相合供者移植患者的T细胞和NK细胞恢复。与相合移植相比,haplo-HCT后早期T细胞恢复延迟且偏向效应记忆表型,NK细胞减少且未成熟亚群扩增;未发生慢性GVHD者记忆Treg细胞PD-1表达更高,提示免疫耐受环境。

要点

  • haplo-HCT后早期T细胞恢复延迟,以效应记忆T细胞为主,初始T细胞显著减少。
  • haplo-HCT后早期NK细胞减少,未成熟CD56brightCD16-亚群优先扩增。
  • IL-15体外预处理可纠正移植后2个月未成熟NK细胞的功能缺陷。

核心结论

  • haplo-HCT后PTCy治疗导致T细胞和NK细胞稳态失衡,表现为T细胞恢复延迟和NK细胞未成熟亚群扩增,可能促进免疫耐受。

研究设计与样本

  • 研究纳入60例接受haplo-HCT后PTCy治疗(骨髓或外周血干细胞移植物)的患者和35例接受HLA相合供者外周血干细胞移植并标准GVHD预防的患者,监测T细胞和NK细胞恢复。

主要发现

  • 与HLA相合移植受者相比,haplo-HCT患者早期T细胞恢复延迟,且偏向效应记忆T细胞,初始T细胞显著减少。
  • haplo-HCT后早期调节性T细胞(Treg)与常规T细胞(Tcon)比值升高,记忆T细胞上PD-1表达增加。
  • 未发生慢性GVHD的haplo-HCT患者,移植后1个月中央和效应记忆CD4+ Treg细胞上PD-1表达更高。
  • haplo-HCT后早期NK细胞减少,未成熟CD56brightCD16- NK细胞优先扩增;移植后1个月质谱流式显示未成熟NK细胞亚群富集,高表达NKG2A、低表达CD57和KIR,3个月时部分恢复。
  • 移植后2个月两组未成熟NK细胞功能受损,体外IL-15预处理可纠正缺陷;未成熟/成熟NK细胞比值升高与巨细胞病毒再激活和慢性GVHD发生率增加相关。

临床怎么用

  • 在haplo-HCT后PTCy治疗患者中,应关注T细胞和NK细胞免疫重建的延迟及未成熟亚群扩增,警惕CMV再激活和慢性GVHD风险。
  • IL-15体外可改善未成熟NK细胞功能,提示早期免疫干预可能优化临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Administration of posttransplant cyclophosphamide (PTCy) has significantly expanded the number of patients undergoing HLA-haploidentical hematopoietic cell transplantation (haplo-HCT). To examine immune reconstitution in these patients, we monitored T- and natural killer (NK)-cell recovery in 60 patients receiving bone marrow or peripheral blood stem cell (PBSC) grafts after haplo-HCT with PTCy and 35 patients receiving HLA-matched donor PBSC grafts with standard graft-versus-host disease (GVHD) prophylaxis. Compared with HLA-matched recipients, early T-cell recovery was delayed in haplo-HCT patients and skewed toward effector memory T cells with markedly reduced naive T cells. We found higher regulatory T (Treg)-cell/conventional T (Tcon)-cell ratios early after HCT and increased PD-1 expression on memory T cells. Within the haplo-HCT, patients who did not develop chronic GVHD (cGVHD) had higher PD-1 expression on central and effector memory CD4+ Treg cells at 1 month after transplant. These findings suggest an immunologic milieu that promotes immune tolerance in haplo-HCT patients. NK cells were decreased early after haplo-HCT with preferential expansion of immature CD56brightCD16- NK cells compared with matched donor transplants. One month after transplant, mass cytometry revealed enrichment of immature NK-cell metaclusters with high NKG2A, low CD57, and low killer-cell immunoglobulin-like receptor expression after haplo-HCT, which partially recovered 3 months post-HCT. At 2 months, immature NK cells from both groups were functionally impaired, but interleukin-15 priming corrected these defects in vitro. Increased immature/mature NK-cell ratios were associated with cytomegalovirus reactivation and increased incidence of cGVHD after haplo-HCT. These homeostatic imbalances in T- and NK-cell reconstitution after haplo-HCT reveal opportunities for early immune-based interventions to optimize clinical outcomes.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Rambaldi B, Kim HT, Reynolds C, et al. Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide. Blood Adv. 2021. PMID: 33496734. doi:10.1182/bloodadvances.2020003005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。